Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
102.32
+2.91 (2.93%)
At close: Mar 9, 2026, 4:00 PM EDT
102.32
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $8.04 billion as of March 9, 2026. Its market cap has increased by 37.41% in one year.
Market Cap
8.04B
Enterprise Value
6.51B
1-Year Change
37.41%
Ranking
Category
Stock Price
$102.32
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $8.04B, an increase of 910.61%. That is a compound annual growth rate of 65.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.82B | 0.05% |
| Dec 31, 2025 | 7.81B | 40.44% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmunityBio | 8.91B |
| Praxis Precision Medicines | 8.65B |
| Vaxcyte | 8.53B |
| ABIVAX Société Anonyme | 8.49B |
| Bio-Techne | 8.43B |
| Arrowhead Pharmaceuticals | 8.38B |
| Axsome Therapeutics | 8.30B |
| Halozyme Therapeutics | 7.95B |